When you think about marijuana stocks, popular Canadian cannabis companies including Aurora Cannabis (NYSE: ACB) and Canopy Growth (NYSE: CGC) likely come to mind. Illinois-based Cresco Labs (OTC: CRLBF) had an impressive start to the year with its first-quarter results, and it continued to shine with its stunning second-quarter results, reported on Aug. 20. Shares of Cresco are down 20% so far this year,…
Canadian cannabis sales are continuing to balloon amidst the coronavirus pandemic. The latest data from Statistics Canada show that in June, retail sales topped 201 million Canadian dollars and were up 8% from May’s total sales. Despite their historic difficulties in generating cash, paying off debts, and avoiding massive writedowns, Aphria (NASDAQ: APHA) and Aurora Cannabis (NYSE: ACB) could be poised…
iAnthus Capital Holdings, Inc. (“iAnthus” or the “Company”) (CSE: IAN), (OTCQX: ITHUF), which owns, operates and partners with regulated cannabis operations across the United States, reminds Secured Noteholders, Unsecured Debentureholders, Equityholders (each as defined below) and any other interested party, that the Company and ICM (as defined below) will attend a hearing (the “Hearing”) before the Supreme Court of British…
Canopy Growth Corporation (“Canopy Growth”) (TSX: WEED) (NYSE: CGC) and Acreage Holdings, Inc. (“Acreage”) (CSE:ACRG.U, OTCQX: ACRGF, FSE:0VZ) (together, the “Companies”) are pleased to announce that Acreage has obtained a final order from the Supreme Court of British Columbia approving the previously announced amended arrangement under section 288 of the Business Corporations Act (British Columbia) involving Canopy Growth (the “Amended…
Canopy Growth Corporation (CGC) closed the most recent trading day at $16.36, moving -0.24% from the previous trading session. READ MORE: https://finance.yahoo.com/news/canopy-growth-corporation-cgc-stock-215009960.html?.tsrc=rss
Pure Extract Technologies, a private, plant-based extraction company, is well positioned to partner with organizations eyeing development in both functional and psychedelic products. The company’s entry into functional medicinal mushrooms and collaboration in the psychedelic space look to be appropriately timed for a sector experiencing rising popularity and growing investment. An article discussing this highlights excerpts from a recent “Forbes”…
Pac Roots (CSE: PACR) (“PacRoots”), a Canadian cannabis company dedicated to producing premium-quality strains and products by leveraging a genetics-focused approach, today announced the closing of a share purchase agreement with 1088070 BC. LTD., a company existing under the laws of Canada (“1088”) and Dave Jonkman and Norm Tapp (together, the “1088 Shareholders” and each, a “1088 Shareholder”). Under the…
Terrace Global Announces Receipt of Pre-License for Outdoor Medical Cannabis Cultivation in Portugal
TORONTO–(BUSINESS WIRE)–Terrace Global Inc. (“Terrace Global” or the “Corporation”) (TSXV: TRCE) is pleased to announce it has been granted a provisional license (the “Pre-License”) from INFARMED, I.P., the Portuguese regulatory authority with oversight over the pharmaceutical industry in Portugal, including medical cannabis (“INFARMED”), at an outdoor medical cannabis site located in Constancia, Portugal (the “Outdoor Property”). The Outdoor Property is…
One with strong financial backing, another with consistent profits — which of these two Canadian pot stocks is a better pick? READ MORE: https://finance.yahoo.com/m/d8053e80-2214-3d85-b83c-653fc21fc078/better-cannabis-stock:-canopy.html?.tsrc=rss
Online investing app Robinhood is a testament to this. Robinhood, which is best-known for its commission-free trading platform and its gifting of free stock to new members, has been particularly successful at courting young and/or novice investors. The following three trends represent potential high-growth opportunities that have, thus far, proved irresistible to Robinhood investors. READ MORE: https://finance.yahoo.com/m/eba3fa90-7fe0-30d6-b27b-3d432fc57dee/3-trends-robinhood-investors.html?.tsrc=rss
Vancouver, British Columbia–(Newsfile Corp. – September 16, 2020) – Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) (the “Company”) has closed its previously announced shares for debt financing. Further to its news release dated August 21, 2020, the Company has settled $625,000 of debt (the “Debt”) payable to the holders (the “Holders”) of convertible debentures of the Company issued on…
If anyone is looking for a successful cannabis story in 2020… look away now. Aurora Cannabis (ACB) continues its relentless search for the bottom as the long-awaited shift in sentiment has failed to materialize. Shares are once again under pressure and lost close to 70% year-to-date.The latest setback can probably be blamed on several pieces of underwhelming news. Last week,…